As of 2023, hospital discharges for hyperplasia of the prostate in Italy were reported to be in the vicinity of 49,000. The forecasted data from 2024 to 2028 show a steady increase, with growth at approximately 1.5% annually. This suggests a gradual rise demand on healthcare systems for managing prostate hyperplasia among Italy's aging population.
Future trends to watch for:
- The impact of medical advancements and early detection on discharge rates.
- Changing demographics, especially among the elderly population, that could influence demand for treatment.
- Policy changes or healthcare innovations that may alter the forecasted trajectory.
